Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 4, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2009. Q3 2009 Summary --------------- - Total revenue...
-
Nov 3, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Dr. William Claypool, M.D., has been appointed to its Board of Directors. Since October 2008, Dr. Claypool has been a Senior Partner at...
-
Nov 2, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or the "Company") today announced that Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. have filed a complaint against Cipher in the...
-
Oct 26, 2009
- Third quarter financial results to be released November 4, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 26 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Oct 7, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has enrolled the first patient in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
Aug 31, 2009
Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer of the Company, is presenting at Rodman & Renshaw's 11th Annual Healthcare...
-
Jul 29, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2009.Q2 2009 Summary --------------- - Finalized FDA...
-
Jul 20, 2009
- Second quarter financial results to be released July 29, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 20 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...
-
May 13, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2009.Q1 2009 Summary ---------------- - Received tentative U.S....
-
May 7, 2009
- First quarter financial results to be released on May 13, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 7 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...
-
Feb 18, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2008.Fiscal 2008 Summary -------------------...
-
Feb 17, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for CIP-TRAMADOL ER, the Company's extended-release...
-
Feb 9, 2009
- Fourth quarter and year end financial results to be released on February 18, 2009 - Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, Feb. 9 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will...
-
Nov 7, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2008.Q3 2008 Summary --------------- - Entered into a...
-
Nov 5, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it will now host its Q3 2008 conference call on Friday, November 7, 2008 at 10:00 a.m. (ET). Cipher invites all interested parties to...
-
Nov 5, 2008
Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer of the Company, will present a corporate update at Rodman & Renshaw's 10th Annual...
-
Oct 29, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) announced that it has been informed that additional time will be required for the U.S. Food and Drug Administration to complete its review of the Company's...
-
Oct 28, 2008
- Third quarter financial results to be released on November 7, 2008 -Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 28 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Oct 27, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has appointed John MacInnis as Vice President, Portfolio Development and Licensing. Mr. MacInnis will be responsible for identifying...
-
Aug 13, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2008.Q2 2008 Summary --------------- - Submitted revised...
-
Aug 7, 2008
- Second quarter financial results to be released on Wednesday August 13, 2008 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Aug. 7 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will...
-
Aug 6, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has entered into a definitive development, distribution and supply agreement with Ranbaxy Pharmaceuticals...
-
Jun 17, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that its revised New Drug Application (NDA) for CIP-TRAMADOL ER, its extended-release formulation of tramadol, has been accepted for review...
-
Jun 6, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that the United States Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-ISOTRETINOIN, the Company's novel...
-
May 13, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that a revised New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) for CIP-TRAMADOL ER, its...